AstraZeneca awaits major boost from the roll-out of Oxford vaccine jab              

British prime minister Boris Johnson during a visit to view the vaccination programme at Chase Farm Hospital in north London, as he NHS is ramps up its vaccination programme.

Shares in AstraZeneca rose as the UK government led by Boris Johnson started to distribute the Oxford University Covid-19 vaccine shot in Britain and the North, but the shares of the British drug giant have still to benefit in a huge way from the programme.

Britain began vaccinating its population with the Oxford and AstraZeneca’s in a world first, racing to give protection to the elderly and vulnerable as a new surge of cases threatened to overwhelm hospitals and as Mr Johnson imposed new school closures.